Silexon is an AI technology company driven by the needs for innovation of biotechnology, with a focus on data, empowering life science research to gain a faster, more systematic, and deeper insights into life, health, and diseases, accelerating innovation and commercialization in the field of biotechnology, and addressing the healthcare needs that have yet to be fulfilled.
S & L Molecules
TCM / Herb Formula
INTELLIGENT LITERATURE SEARCH AND ANALYSIS
Uses artificial intelligence and knowledge mapping technologies to help life science research by providing project decision-making reference, implementation solutions and innovative ideas for efficient innovation and R & D.
TARGET PRECISE DISCOVERY
Uses AI technology to accurately screen and predict disease diagnosis bio-markers and treatment targets by combining massive literature texts and comprehensive biological data.
EFFICIENT PATENT MINING
Uses AI technology to realize efficient patent novelty search, feasibility analysis, claims analysis and comparison, knowledge map construction, patent writing and multilingual translation.
MOLECULAR GENERATION AND OPTIMIZATION
Automatic extraction and analysis of drug patent / literature data to accelerate the drug development process, and rapid screening of potential active compounds for a given target in a large-scale molecular library based on deep learning models.
INNOVATIVE DISCOVERY OF TCM AND HERBAL DRUGS
Discovery of active molecules of traditional Chinese medicine (TCM) and herbs based on deep learning model, clinical analysis of TCM prescriptions (medicinal materials), clinical evaluation of active molecules, druggability analysis, molecular generation or optimization, and process research.
NUCLEIC ACID DRUG DESIGN
Provides end-to-end solutions for nucleic acid drug design, nucleic acid molecule generation, and optimization, significantly improving key indicators of nucleic acid sequences.
SMALL MOLECULE DRUG DESIGN
Combining the target structure with existing active molecules, following various scenarios such as pharmacochemical principles for molecular generation and optimization.
Accelerating the commercial transformation of biotechnology and pharmaceutical IPs with AI-based data analysis of supply - demand correlation.
Precisely matching supply with demand among tens of thousands of biotechnology and pharmaceutical firms worldwide based on IP (patent) portfolio, scientific research papers, product pipelines, enterprise situation, investment case analysis.
Empowered by AI to efficiently realize patent retrieval, automatic data extraction and analysis, claims analysis, knowledge graph construction, patentability research, transformation between technical solutions and patent application documents, and multilingual translation.
Our Customers / Partners
BDE.top is a highly intelligent R & D system based on General Artificial Intelligence (AGI) technology and a specially trained GPT model developed by Silexon. It can understand, learn, and execute tasks in a wide range of domains, significantly improving the efficiency of life science research and development (up to 90% or more) and reducing costs, including:
General Domains: intelligent literature search and analysis and efficient patent mining that facilitate fund application, scientific research paper drafting and patent filing, etc.);
Specialty Domains: drug target analysis, small molecule and biological agent (mRNA sequence) design and optimization, TCM and herbal drug discovery, etc.
（Biology Discovery Engine）